Monogram Orthopaedics Inc. Common Stock (MGRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has a cash flow conversion efficiency ratio of -0.267x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.30 Million) by net assets ($8.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MGRM market cap for the company's overall valuation and market capitalisation.
Monogram Orthopaedics Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Monogram Orthopaedics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their cash flow conversion efficiency. See Monogram Orthopaedics Inc. Common Stock (MGRM) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA
|
-0.130x |
|
Newron Pharmaceuticals SpA
SW:NWRN
|
0.119x |
|
Aviat Networks Inc
NASDAQ:AVNW
|
0.012x |
|
Global Water Resources Inc
NASDAQ:GWRS
|
0.097x |
|
Panora Gayrimenkul Yatirim Ortakligi AS
IS:PAGYO
|
0.011x |
|
Poya International Co Ltd
TWO:5904
|
0.197x |
|
Santhera Pharmaceuticals Holding AG
SW:SANN
|
1.199x |
|
Bioteque
TWO:4107
|
0.075x |
Annual Cash Flow Conversion Efficiency for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual cash flow conversion efficiency of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. View MGRM share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.50 Million | $-13.97 Million | -0.963x | +4.72% |
| 2023-12-31 | $13.40 Million | $-13.54 Million | -1.011x | +50.18% |
| 2022-12-31 | $4.15 Million | $-8.42 Million | -2.029x | +22.46% |
| 2021-12-31 | $3.50 Million | $-9.17 Million | -2.617x | -141.63% |
| 2020-12-31 | $4.99 Million | $-5.40 Million | -1.083x | -128.37% |
| 2019-12-31 | $-274.63K | $-1.05 Million | 3.817x | +1630.44% |
| 2018-12-31 | $-1.39 Million | $-306.87K | 0.221x | -75.86% |
| 2017-12-31 | $-677.81K | $-619.37K | 0.914x | -- |
About Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more